Clinical Trials Directory

Trials / Completed

CompletedNCT02252497

Tranexamic Acid in Total Hip Arthroplasty.

Tranexamic Acid in Total Hip Arthroplasty: Single Preoperative Administration vs Perioperative Administration. A Randomized Control Trial.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
168 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare a single preoperative dose of 1g of tranexamic acid (TXA) versus a preoperative dose of 1g of TXA followed by a continuous infusion of 1g over height hours on blood loss.

Detailed description

The purpose of this study is to compare a single preoperative dose of 1g of tranexamic acid (TXA) versus a preoperative dose of 1g of TXA followed by a continuous infusion of 1g over eight hours on blood loss. The efficacy of TXA on blood loss is greatly influenced by the timing of its administration relative to surgery. In total hip arthroplasty, TXA should be started before surgery. However the optimal duration of TXA administration in hip arthroplasty is unknown. Numerous studies have shown that a single preoperative administration of TXA is effective. Yet indirect comparisons indicate a higher efficacy of TXA started before surgery and followed with a continuous infusion or repeated boluses. Our hypothesis is that a single preoperative administration of TXA is not sufficient to maintain therapeutic concentrations of TXA in the postoperative period. In addition a pharmacokinetic/pharmacodynamic study will be performed to identify the contribution of TXA plasma concentration as a predictor of blood loss.

Conditions

Interventions

TypeNameDescription
DRUGActive comparator : Tranexamic Acid (Exacyl)* 1g Exacyl Intra Venous, just before surgery * Then infusion of 1g of Exacyl over eight hours .
DRUGPlacebo comparator : physiologic serum* 1g Intra Venous just before surgery * Then infusion of 1g of physiologic serum over eight hours

Timeline

Start date
2014-04-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2014-09-30
Last updated
2016-03-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02252497. Inclusion in this directory is not an endorsement.